Another biopharma tried buying Amicus before BioMarin's $4.8B deal
在BioMarin达成48亿美元交易前，另一家生物制药公司曾试图收购爱美医疗(Amicus Therapeutics)

The road to Amicus Therapeutics’ $4.8 billion exit to BioMarin last month included a previously undisclosed acquisition offer from another biopharma, quiet dinners between CEOs, and a months-long push to settle a legal dispute.
爱美医疗上个月以48亿美元出售给BioMarin的交易之路，包含此前未披露的一家生物制药公司的收购要约、两位首席执行官之间的私下晚宴，以及为解决法律争端而进行的、持续数月的努力。